Your browser doesn't support javascript.
loading
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius, S; Ruprecht, K; Stellmann, J P; Huss, A; Ayzenberg, I; Willing, A; Trebst, C; Pawlitzki, M; Abdelhak, A; Grüter, T; Leypoldt, F; Haas, J; Kleiter, I; Tumani, H; Fechner, K; Reindl, M; Paul, F; Wildemann, B.
Afiliação
  • Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany. sven.jarius@med.uni-heidelberg.de.
  • Ruprecht K; Otto Meyerhof Center, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. sven.jarius@med.uni-heidelberg.de.
  • Stellmann JP; Department of Neurology, Charité - University Medicine Berlin, Berlin, Germany.
  • Huss A; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Zentrum für Molekulare Neurobiologie Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Ayzenberg I; Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Willing A; Department of Neurology, University of Ulm, Ulm, Germany.
  • Trebst C; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
  • Pawlitzki M; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Zentrum für Molekulare Neurobiologie Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Abdelhak A; Department of Neurology, Hannover Medical School, Hanover, Germany.
  • Grüter T; Department of Neurology, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Leypoldt F; Department of Neurology, University of Ulm, Ulm, Germany.
  • Haas J; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
  • Kleiter I; Department of Neurology and Institute of Laboratory Medicine, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Tumani H; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Fechner K; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
  • Reindl M; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany.
  • Paul F; Department of Neurology, University of Ulm, Ulm, Germany.
  • Wildemann B; Specialty Clinic of Neurology Dietenbronn, Schwendi, Germany.
J Neuroinflammation ; 15(1): 88, 2018 Mar 19.
Article em En | MEDLINE | ID: mdl-29554927
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Esclerose Múltipla Crônica Progressiva / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Esclerose Múltipla Crônica Progressiva / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha